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ATP-dependent para-aminohippurate transport by the apical by a high transport capacity and by a broad substrate
multidrug resistance protein MRP2. specificity [1–3]. Whereas the uptake of organic anions
Background. Para-aminohippurate (PAH), a widely used has been defined relatively well, the mechanisms respon-model substrate for organic anion transport in proximal tubule
sible for transport of compounds through the tubularepithelia, was investigated as a substrate for the apical multi-
cells and the secretion into the tubular lumen are less welldrug resistance protein MRP2 (symbol ABCC2). This ATP-
dependent export pump for anionic conjugates and additional understood. Among the secreted amphiphilic organic
amphiphilic anions was cloned recently and localized to the anions are drugs such as penicillins, cephalosporins, and
apical membrane of proximal tubules in human and rat kidney. diuretics, conjugated toxic agents, and the prototypicMethods. Membrane vesicles from HEK-MRP2 cells con-
anion para-aminohippurate (PAH) [1, 3]. PAH secretiontaining recombinant human MRP2 and from control vector-
also involves a two-step process, starting with its uptaketransfected HEK-Co cells were incubated with various concen-
trations of [3H]PAH, and the net ATP-dependent transport across the basolateral membrane of proximal tubule
into inside-out vesicles was determined. Comparative studies cells. In all species studied so far, extracellular PAH is
were performed with membrane vesicles containing recombi-
exchanged for intracellular 2-oxoglutarate by the baso-nant human MRP1.
lateral PAH/2-oxoglutarate antiporter cloned recentlyResults. Transport rates at 10 mmol/L PAH were 21.9 6 1.9
and 1.6 6 0.4 pmol 3 mg protein21 3 min21 (means 6 SEM, [4–8]. For the second step, the exit of PAH across the
N 5 10) with membrane vesicles from HEK-MRP2 and HEK-Co apical membrane into the tubular lumen, several differ-
cells, respectively. The Km value for PAH was 880 mmol/L. ent mechanisms have been discussed on the basis of
The high-affinity substrate leukotriene C4 and the inhibitor of studies with isolated renal brush border membrane vesi-MRP-mediated transport, MK571, inhibited MRP2-mediated
cles, suggesting an antiporter for PAH secretion [9, 10].transport of PAH (100 nmol/L) with IC50 values of 3.3 and 4.0
mmol/L, respectively. The nephrotoxic mycotoxin ochratoxin Fluorescence imaging experiments characterized the
A inhibited MRP2-mediated PAH transport with an IC50 value transport of amphiphilic anions from tubular cells to the
of 58 mmol/L. Ochratoxin A was itself a substrate for MRP2. tubular lumen as a carrier-mediated uphill process [11, 12].Conclusions. PAH is a good substrate for the ATP-depen-
Cross-inhibition experiments suggested that in movingdent export pump MRP2. The localization and function of
from cell to tubular lumen fluorescein, carboxyfluores-MRP2 indicate that this unidirectional transport protein con-
tributes to the secretion of PAH and other amphiphilic anions cein diacetate, probenecid, PAH, and bimane conjugates
into the lumen of kidney proximal tubules. all compete for a common transporter [11, 12].
Recently, MRP2, the multidrug resistance protein iso-
form characterized by its apical localization in polarized
In the kidney, active transport predominates in the cells such as hepatocytes [13–16], has been identified in
proximal tubules, and separate transport systems exist rat [17] and human [18] kidney, and localized to the
for the secretion of organic anions and cations into the apical membrane of proximal tubule epithelia. In earlier
tubular lumen [1–3]. Uptake across the basolateral mem- investigations, MRP2 was designated as the canalicular
brane is followed by active transport across the apical (or multidrug resistance protein [14] or as the canalicular
luminal) membrane. Both processes are characterized multispecific organic anion transporter of hepatocytes
[15]. MRP2 and the human multidrug resistance protein
MRP1 [19] are presently the best characterized membersKey words: adenosine 59-triphosphate-dependent transport, conjugate
export pump, luminal transport, PAH, multiple drug resistance protein. of this family of adenosine 59-triphosphate (ATP)-depen-
dent exporter proteins. Human MRP1 is sorted to theReceived for publication June 14, 1999
basolateral membrane of transfected polarized cells [20]and in revised form November 10, 1999
Accepted for publication November 11, 1999 and is detected in many different cell types [21]. MRP2
and MRP1 share a similar and broad substrate specificity,Ó 2000 by the International Society of Nephrology
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which comprises the glutathione S-conjugate leukotriene (Eggenstein, Germany). Culture media and supplements
were from Sigma-Aldrich Chemie (Deisenhofen, Ger-C4 (LTC4) and many endogenous and xenobiotic lipo-
philic compounds conjugated to glutathione, glucuronate, many).
or sulfate [22–28].
CellsOf special interest for the overall handling of xenobiot-
ics by the kidney in the intact organism is the interaction Human embryonic kidney (HEK293) cells permanently
expressing high levels of MRP2 (HEK-MRP2) were gen-of the different transporters during secretion and reab-
sorption. The resulting intracellular concentrations of the erated in our laboratory using the cDNA encoding hu-
man MRP2, as defined by the EMBL/GenBank acces-xenobiotics play a pivotal role for their potential nephro-
toxicity. Contamination of cereals and grains with Asper- sion X96395 [28]. Control HEK293 cells were transfected
with the parental pcDNA3.1 vector (HEK-Co). All HEKgillus and Penicillium fungi may lead to formation of the
mycotoxin ochratoxin A (OTA) [29], which has been cells were cultured in minimum essential medium (MEM)
containing 10% fetal calf serum (FCS) supplementedassociated with the induction of Balkan nephropathy in
humans and porcine nephropathy, as well as carcinogen- with l-glutamine (2 mmol/L), penicillin (100 U/mL), and
streptomycin (100 mg/mL, 0.17 mmol/L). All cell linesesis [reviewed in 30]. The proximal tubule of the kidney
is a primary site targeted in OTA-induced nephrotoxic- were kept in a humidified incubator (5% CO2, 378C).
HeLa T5 cells transfected with a vector containing theity, and OTA was shown to interact with PAH and or-
ganic anion transporters both in the basolateral and the MRP1-coding sequence and control HeLa C1 cells trans-
fected with the pRc/CMV vector [33] were kindly pro-brush border membrane [31]. Moreover, acute OTA ex-
posure impairs postproximal nephron function [30]. vided by Drs. R.G. Deeley and S.P.C. Cole (Cancer
Research Laboratories, Queen’s University, Kingston,For the apical secretion of amphiphilic anions, includ-
ing PAH and OTA, into the lumen of proximal tubules, Ontario, Canada). HeLa cell lines were grown in RPMI
medium with 10% FCS under the selection pressure ofMRP2 is a suitable candidate transporter because of its
localization in the luminal membrane [17, 18] and be- G418 (Geneticint).
cause of its broad substrate specificity [26–28]. However,
Membrane vesicle preparationdirect information on the role of MRP2 in the renal excre-
tion of these xenobiotics has been lacking. Therefore, we Plasma membrane vesicles from HEK-MRP2, HEK-Co,
HeLa T5, and HeLa C1 cells were prepared from hypo-used in the present study isolated membrane vesicles from
HEK cells expressing recombinant human MRP2 for di- tonically lyzed cells as described previously [22, 23, 26, 28].
In the case of HEK cell lines, butyrate (final concentra-rect measurements of ATP-dependent transport of PAH
and OTA. For comparison, transport mediated by the tion 5 or 10 mmol/L) was added to the culture medium 24
hours before membrane preparation to enhance MRP2basolateral transporter MRP1 was determined. Potent in-
hibitors and substrates of ATP-dependent MRP-mediated expression [28]. Membrane vesicles were frozen and
stored in liquid nitrogen until use.transport, such as the anionic quinoline derivative MK571,
cyclosporine A (CsA), and LTC4 [14, 22, 23], served to
Vesicle transport measurementscharacterize this transport process in further detail. Our
studies demonstrate that MRP2 can function as a luminal Adenosine 59-triphosphate-dependent transport of
[3H]PAH or of the fluorescent OTA was measured byPAH transporter in kidney proximal tubules and thus
mediate, at least in part, the step in PAH transport identi- centrifugation of the vesicles through a gel matrix using
NICK-spin columns [26]. Membrane vesicles (20 mg pro-fied earlier on the basis of functional studies [32].
tein) were incubated in the presence of 4 mmol/L ATP,
10 mmol/L MgCl2, 10 mmol/L creatine phosphate, 100METHODS
mg/mL creatine kinase, and the substrate, in an incubation
Materials buffer containing 250 mmol/L sucrose and 10 mmol/L
Tris/HCl, pH 7.4. The final incubation volume was 55Para-amino[2-3H-glycyl]hippurate (0.18 or 1.48 TB/
mmol) was obtained from American Radiolabeled Chem- mL. The substrate and inhibitor concentrations are given
in the respective figure legends. NICK-spin columnsicals (St. Louis, MO, USA). PAH, CsA, and OTA were
from Sigma Chemical Co. (St. Louis, MO, USA). MK571 (0.17 g Sephadex G-50 per 3.3 mL) were prepared by
rinsing with 250 mmol/L sucrose and 10 mmol/L Tris/(3-[{3-(2-[7-chloro-2-quinolinyl]ethenyl)phenyl}-{(3-di-
methylamino-3-oxopropyl)-thio}-methyl]-thio)-propa- HCl (pH 7.4) and centrifuged at 400 3 g for four minutes
at 48C immediately before use. Aliquots (15 or 20 mL)noic acid was from Cayman Chemical (Ann Arbor, MI,
USA). LTC4 was purchased from Reatec GmbH (Weit- of the incubations were taken at the indicated time points
and immediately loaded onto Sephadex G-50 columns.erstadt, Germany). NICK-spin columns and Sephadex
G50 fine were from Pharmacia Biotech (Freiburg, Ger- The columns were rinsed with 180 mL of incubation
buffer and centrifuged at 400 3 g for four minutes atmany). G418 (Geneticint) was from Life Technologies
Leier et al: MRP2-mediated ATP-dependent PAH transport1638
Fig. 1. Adenosine 59-triphosphate (ATP)-dependent
transport of [3H] para-aminohippurate (PAH) medi-
ated by the multidrug resistance proteins MRP2 and
MRP1. Membrane vesicles (20 mg protein) from
MRP2-transfected HEK-MRP2 cells and control vec-
tor-transfected HEK-Co cells (A and B), as well as
membrane vesicles from MRP1-transfected HeLaT5
cells and control vector-transfected HeLaC1 cells (C
and D), were incubated with 10 mmol/L [3H]PAH in
the presence of 4 mmol/L ATP (m). In the control
incubations, ATP was replaced by 4 mmol/L AMP-
PCP (.). The net ATP-dependent transport was cal-
culated by subtracting values obtained in the presence
of AMP-PCP from those obtained in the presence
of ATP (j in B and D). Control vector-transfected
cell membrane vesicles exhibit a low rate of ATP-
dependent transport (h in B and D). Mean values 6
SEM (N 5 10) from two separate transport experi-
ments with five separate transport incubations each
are shown.
48C. The effluents of the [3H]PAH transport incubations RESULTS
were collected and assayed for vesicle-associated radio- ATP-dependent PAH transport mediated by MRP2
activity. In control experiments, ATP was replaced by and MRP1
an equal concentration of the nonhydrolyzable ATP ana- To identify PAH as a substrate for the apical multidrug
logue AMP-PCP. Rates of net ATP-dependent transport resistance protein, MRP2, membrane vesicles from cells
were calculated by subtracting the blank values obtained expressing recombinant MRP2 were incubated with 10
in the presence of AMP-PCP from those measured in the mmol/L [3H]PAH in the presence of ATP or, for control
presence of ATP. For determination of kinetic constants, measurements, in the presence of the nonhydrolyzable
ATP-dependent [3H]PAH transport was measured in the ATP analogue AMP-PCP (Fig. 1A). For comparison,
concentration range from 50 to 1600 mmol/L. corresponding assays were performed with membrane
The effluents of the incubations with the fluorescent vesicles from HeLa T5 cells expressing recombinant
OTA were collected into vials containing 20 mL of solubi- MRP1 (Fig. 1C). The ATP-dependent transport rates
lization buffer (1% Triton X-100 in Tris/HCl, pH 7.4; (Fig. 1 B, D) demonstrate that [3H]PAH is transported
final concentration 0.1% Triton X-100) to release the by MRP2 (Fig. 1C), as well as by MRP1 (Fig. 1D). In
intravesicularly trapped fluorescent substrate by the de- addition, transport of 10 mmol/L [3H]PAH was measured
tergent [34]. Subsequently, the samples were diluted with under the same conditions with membrane vesicles from
600 mL 0.1% Triton X-100, 225 mmol/L sucrose, and 20 the respective vector-transfected control cells, which ex-
mmol/L Tris/HCl (pH 7.4). An aliquot of 800 mL of each press a low level of endogenous MRP isoforms [28, 33].
sample was measured fluorometrically (RF-510 fluores- The respective rates for ATP transport were 21.9 6 1.9,
cence spectrophotometer; Shimadzu, Duisburg, Ger- 1.6 6 0.4, 17.4 6 1.9, and 7.9 6 1.8 pmol 3 mg protein21 3
many) at an excitation wavelength of 375 nm and an min21 (means 6 SEM, N 5 10) for HEK-MRP2, HEK-Co,
emission wavelength of 440 nm [35] at a gain setting of HeLa T5, and HeLa C1 membrane vesicles, respectively.
50 and an averaging time of one second. A calibration Similar transport assays were performed at 10 mmol/L
curve (0 to 0.5 nmol/L OTA) was prepared in triplicate [3H]PAH with membrane vesicle suspensions from MRP2
to calculate the amount of OTA transported into the (Fig. 2) as well as from MRP1 transfectants in order to
study the effect of medium osmolarity. Transport ratesHEK-MRP2 membrane vesicles.
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Fig. 2. Osmolarity dependence of ATP-dependent MRP2-mediated
[3H]PAH transport. Membrane vesicles (20 mg protein) from MRP2-
transfected HEK-MRP2 cells were incubated with 10 mmol/L [3H]PAH
in the presence of 4 mmol/L ATP, or in control incubations with 4
mmol/L AMP-PCP, in suspensions containing sucrose concentrations
ranging from 250 mmol/L (isotonic condition) to 1500 mmol/L. Net
ATP-dependent transport, calculated as described in the legend to
Figure 1, is plotted against the reciprocal sucrose concentration in the
transport incubation. Mean values 6 SEM (N 5 8) from two separate
experiments with four separate transport incubations each are shown.
obtained with both vesicle suspensions decreased with Fig. 3. Determination of the kinetic constants for MRP2- and MRP1-
increasing concentrations of sucrose, indicating transport mediated [3H]PAH transport. Membrane vesicles from HEK-MRP2
and HeLa T5 cells expressing recombinant MRP2 and MRP1, respec-into an osmotically sensitive space and not binding to
tively, were incubated with PAH in the concentration range from 50
the vesicle surface. to 1600 mmol/L. The net ATP-dependent transport rates were calculated,
and the kinetic constants were determined according to Lineweaver and
Burk. (A) Mean values from four separate experiments, each performedKinetic constants for MRP2- and MRP1-mediated
with duplicate determinations. (B) Mean values from two separate
ATP-dependent PAH transport experiments, each with duplicate determinations.
For determination of Km and Vmax values for PAH
transport mediated by MRP2 and MRP1, transport was Effect of OTA on MRP-mediated PAH transport
measured in the concentration range of 50 to 1600 mmol/L The nephrotoxic mycotoxin OTA was tested as a pos-
(Fig. 3). The Km value for MRP2 was 880 mmol/L and sible inhibitor of ATP-dependent [3H]PAH transport.
the one for MRP1 was 372 mmol/L, and the correspond- Membrane vesicles from HEK-MRP2 and HeLa T5 cells
ing Vmax values were 2.3 and 0.54 nmol 3 mg protein21 3 were incubated with 100 nmol/L [3H]PAH in the pres-
ence of OTA at concentrations between 10 and 100min21 for MRP2 and MRP1, respectively.
mmol/L. The IC50 values were about 58 mmol/L for MRP2
and 53 mmol/L for MRP1, as shown in Figure 5.Inhibition of MRP-mediated ATP-dependent
PAH transport Identification of OTA as a substrate for
Membrane vesicles from HEK-MRP2 and HeLa T5 MRP2-mediated transport
cells were incubated with 100 nmol/L [3H]PAH in the Membrane vesicles from HEK-MRP2 were incubated
presence of the high-affinity MRP substrate LTC4, the with OTA to test whether this fluorescent compound is
MRP inhibitor MK571, and CsA at the concentrations a substrate for MRP2. As shown in Figure 6, OTA was
transported by MRP2. The net ATP-dependent transportindicated in Figure 4. LTC4 and MK571 inhibited the
for OTA, at a concentration of 200 mmol/L, was 1.2 6 0.1MRP2- and the MRP1-mediated [3H]PAH transport
nmol 3 mg protein21 3 min21 (mean 6 SD, N 5 4).markedly, with IC50 values between 3.3 and 4.9 mmol/L
(Fig. 4). CsA inhibited MRP1-mediated transport with
DISCUSSIONan IC50 value of 3.3 mmol/L, whereas the IC50 value for
MRP2 was above 10 mmol/L, in a concentration range Our results indicate that MRP2, the multidrug resis-
tance protein isoform localized to the apical membranein which CsA solubility becomes limiting.
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Fig. 4. Inhibition of ATP-dependent [3H]PAH
transport, mediated by recombinant MRP2
(j) or MRP1 (h), by (A) LTC4, (B) MK 571,
and (C) CsA. Transport of 100 nmol/L [3H]PAH
was measured in membrane vesicles from
HEK-MRP2 and HeLa T5 cells, expressing
recombinant MRP2 and MRP1, respectively,
in the presence or absence of inhibitors, as
indicated. The net ATP-dependent transport
and percentage of inhibition were calculated
for each inhibitor concentration in compari-
son to control incubations without inhibitor.
Transport rates for MRP2- and MRP1-medi-
ated transport in the absence of inhibitor were
0.68 6 0.03 pmol 3 mg protein21 3 min21 and
0.40 6 0.02 pmol 3 mg protein21 3 min21,
respectively. In A, the IC50 for LTC4 is 3.3
mmol/L for MRP2 and 4.9 mmol/L for MRP1;
in B, the IC50 for MK571 is 4.0 mmol/L for
MRP2 and 3.3 mmol/L for MRP1; in C, the
IC50 for CsA is .10.0 mmol/L for MRP2 and
3.3 mmol/L for MRP1. Mean values 6 SEM
from eight different experiments, each with
five duplicate determinations, are shown.
Each inhibitor concentration was tested in two
separate incubations, with five duplicate de-
terminations each.
of polarized cells, is part of the PAH transport systems
in proximal tubule epithelia of the kidney. Measure-
ments of ATP-dependent transport into membrane vesi-
cles from HEK cells expressing recombinant MRP2 [28]
demonstrate that PAH is a good substrate for this apical
export pump (Figs. 1 and 3). The Vmax/Km ratio for PAH
as a substrate for MRP2 was 2.6 mL 3 mg21 3 min21
(Fig. 3), as compared with 20 and 351 mL 3 mg21 3 min21
for the prototypic substrates 17b-glucuronosyl estradiol
and LTC4, respectively [28]. In addition, PAH was trans-
ported by recombinant human MRP1 (Figs. 1 and 3).
This is in line with the observations indicating that MRP2
and MRP1 have a similar substrate specificity [26, 28].
PAH transport was inhibited by similar concentrations
of LTC4 and of the LTD4 analogue MK571, as well as by
CsA, which is a known inhibitor for several ATP-depen-
dent export pumps [36] (Fig. 4). CsA and LTC4 were also
shown to inhibit organic anion secretion into the lumen
of intact kidney proximal tubules, suggesting the pres-
ence of an MRP2-like apical transporter [12, 37]. Al-
though additional MRP isoforms (for example, MRP3-6)
have been identified recently [38], MRP2 is the only
isoform detected in the apical membrane domain of po-
larized cells [27, 28, 39]. No information is currently
Fig. 5. Inhibition of ATP-dependent MRP2- and MRP1-mediatedavailable on the localization of endogenous MRP1 in PAH transport by ochratoxin A (OTA). Transport of 100 nmol/L
kidney, although transfection studies have indicated that [3H]PAH was measured in membrane vesicles containing recombinant
MRP2 (j) or MRP1 (h), in the presence of the OTA concentrationsrecombinant MRP1 is sorted to the lateral membrane
indicated. The net ATP-dependent transport and percentage of inhibi-
of porcine kidney cells [20]. Another basolateral isoform tion were calculated for each inhibitor concentration in comparison to
control incubations without inhibitor. Transport rates for MRP2- andof the MRP family, MRP3, is expressed in human kidney
MRP1-mediated transport in the absence of OTA are given in theonly at a very low level [39]. Thus, there is no evidence
legend to Figure 4. The IC50 is 53 mmol/L for MRP1 and 58 mmol/Lat present suggesting a functionally important role of for MRP1. Each inhibitor concentration was tested in two separate
incubations with five duplicate determinations each.MRP isoforms other than MRP2 in proximal tubules
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cassette transporter localized to the proximal tubule api-
cal membrane. MDR1 P-glycoprotein markedly differs
in its function and amino acid sequence from MRP1 and
MRP2 [16, 19]. MDR1 P-glycoprotein functions in the
ATP-dependent export of a broad spectrum of lipophilic,
mostly cationic, substances [41, 42], whereas MRP2 and
MRP1 mediate the transport of amphiphilic anions such
as leukotriene LTC4 and several other endogenously
formed glutathione, glucuronate, and sulfate conjugates
[22–28]. Moreover, MRP1 and MRP2 also transport cer-
tain unconjugated compounds, such as the amphiphilic
penta-anion Fluo-3 [34] and, as shown in this study, the
amphiphilic anions PAH and OTA (Figs. 1 and 6).
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mmol/L OTA in the presence of 4 mmol/L ATP (m). Control incubations
were performed in the presence of 4 mmol/L AMP-PCP (.). Vesicle-
associated OTA fluorescence was determined as described in the Meth-
APPENDIXods section, and the net ATP-dependent transport was calculated by
subtracting the values obtained in the presence of AMP-PCP from Abbreviations used in this article are: CsA, cyclosporin A; HEK293,
those obtained in the presence of ATP (j). Mean values 6 SD from human embryonic kidney cell line; HEK-Co, HEK cells transfected
four separate incubations are shown. with the parental pcDNA3.1 vector; HEK-MRP2, HEK cells stably
transfected with cDNA encoding human MRP2; HeLa C1, HeLa cells
transfected with the pRc/CMV vector; HeLa T5 cells, HeLa cells trans-
fected with a vector containing the MRP1-coding sequence; LTC4,
leukotriene C4; MEM, minimum essential medium; MK571 (3-[{3-(2-of the kidney. In analogy to the role of MRP2 in the [7-chloro-2-quinolinyl]ethenyl)phenyl}-{(3-dimethylamino-3-oxopro-
hepatobiliary elimination of amphiphilic organic anions pyl)-thio}-methyl]-thio)-propanoic acid; MRP1, multiple drug resis-
tance protein 1 (also multidrug resistance-associated protein; symbol[16], we conclude that it is MRP2 that decisively contrib-
ABCC1); MRP2, apical isoform of MRP family (also cMRP, for canali-utes to the secretion of these substances by proximal
cular multidrug resistance protein, or cMOAT for canalicular multispe-
tubule epithelia into the tubular lumen. If basolaterally cific organic anion transporter; symbol ABCC2); OTA, ochratoxin A;
PAH, para-aminohippurate.localized MRP isoforms are expressed in kidney proximal
tubules at a low level, they should not affect the overall
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